: The increase in the use of mobile apps since the COVID-19 pandemic, even among people with multiple sclerosis (PwMS) and health care providers (HCPs), has enabled access to reliable information, symptoms monitoring and management, and social connections. The pandemic has undoubtedly contributed to the acceleration of the “digital revolution.” But how far has it progressed for the MS communities?
Methods
: Italian Google Play and App Store were queried, selecting MS-specific apps in English or Italian language and usable by a wide public.
Results:
Fifty-four (n = 54) MS-specific apps were identified; most were PwMS-oriented (83%), free of charge (94%), and in English language (76%). The 45 PwMS-oriented apps focused on increasing MS knowledge (71%), tracking symptoms (33%), and promoting networking with peers or HCPs (38%). The 13 HCPs-oriented tools addressed education and updates on MS (62%), disease assessment and management (54%), and research (15%). Google Search tool was also queried to find non-MS–specific apps to fulfill some unmet domains (as sleep, pain, sexual or mental health). Twenty-four additional apps were listed to provide a valuable contribution.
Conclusion
: The “digital revolution” led to increasingly customized tools for PwMS, especially as m-health or social-networking apps. However, apps to support other specific MS-relevant domains, appealing HCPs-oriented apps, and specific mobile tools for MS caregivers are still lacking. The absence of data assessing the usability and quality of MS apps in ecologically contexts leads to not reliable conclusions about potential benefits. A strong dialogue between MS communities and the digital industry is encouraged to fill this gap.
Get full access to this article
View all access options for this article.
References
1.
Clemente-SuárezVJ, DalamitrosAA, Beltran-VelascoAI, et al.Social and psychophysiological consequences of the COVID-19 pandemic: An extensive literature review. Front Psychol, 2020; 11:580225; doi: 10.3389/fpsyg.2020.580225
2.
WaltonC, KingR, RechtmanL, et al.Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler, 2020; 26(14):1816–1821; doi:10.1177/1352458520970841
3.
Pashazadeh KanF, HoseinipalangiZ, AhmadiN, et al.Global, regional and national quality of life in patients with multiple sclerosis: A global systematic review and meta-analysis. BMJ Support Palliat Care, 2022; 12:158–166; doi: 10.1136/bmjspcare-2020-002604
4.
MaguireR, MaguireP. Caregiver burden in multiple sclerosis: Recent trends and future directions. Curr Neurol Neurosci Rep, 2020; 20(7):18. doi: 10.1007/s11910-020-01043-5
QudahB, LuetschK. The influence of mobile health applications on patient–healthcare provider relationships: A systematic, narrative review. Patient Educ Couns, 2019; 102(6):1080–1089; doi: 10.1016/j.pec.2019.01.021
11.
GriffinN, KehoeM. A questionnaire study to explore the views of people with multiple sclerosis of using smartphone technology for health care purposes. Disabil Rehabil, 2018; 40(12):1434–1442; doi: 10.1080/09638288.2017.1300332
12.
VentolaCL.Mobile devices and apps for health care professionals: uses and benefits. P T, 2014; 39(5):356–364.
13.
StuartJ, O'DonnellK, O'DonnellA, et al.Online social connection as a buffer of health anxiety and isolation during COVID-19. Cyberpsychol Behav Soc Netw, 2021; 24(8):521–525; doi: 10.1089/cyber.2020.0645
GiuntiG, Guisado-FernandezE., CaulfieldB.Connected Health in Multiple Sclerosis: A mobile applications review. IEEE 30th International Symposium on Computer-Based Medical Systems (CBMS), 2017; doi:10.1109/CBMS.2017.27
18.
GiuntiG, Guisado FernándezE, Dorronzoro ZubieteE, et al.Supply and demand in mHealth apps for persons with multiple sclerosis: Systematic search in app stores and scoping literature review. JMIR Mhealth Uhealth, 2018; 6(5):e10512; doi: 10.2196/10512
19.
VacchiL, ZironeE, CavalettiGA, et al.mHealth to support MS community during Covid-19 pandemic. (Videoposter). Presented at Annual Meeting Milan Center for Neuroscience—NEUROMI 2020; December 18, 2020; Milan, Italy.
20.
VacchiL, ZironeE, CavalettiGA, et al.Mobile applications to support MS-related communities. (Videoposter). Presented at Annual Meeting Milan Center for Neuroscience—NEUROMI 2021; 2021; Milan, Italy.
21.
SalimzadehZ, DamanabiS, KalankeshLR, et al.Mobile applications for multiple sclerosis: A focus on self-management. Acta Inform Med, 2019; 27(1):12–18; doi: 10.5455/aim.2019.27.12-18
22.
MarziniakM, BrichettoG, FeysP, et al.The use of digital and remote communication technologies as a tool for multiple sclerosis management: Narrative review. JMIR Rehabil Assist Technol, 2018; 5(1):e5; doi: 10.2196/rehab.7805
23.
CohenM.Connected health and multiple sclerosis. Rev Neurol (Paris), 2018; 174(6):480–485; doi: 10.1016/j.neurol.2018.03.008
24.
SimblettSK, EvansJ, GreerB, et al.Engaging across dimensions of diversity: A cross-national perspective on mHealth tools for managing relapsing remitting and progressive multiple sclerosis. Mult Scler Relat Disord, 2019; 32:123–132; doi: 10.1016/j.msard.2019.04.020
25.
MarrieRA, LeungS, TyryT, et al.Use of eHealth and mHealth technology by persons with multiple sclerosis. Mult Scler Relat Disord, 2019; 27:13–19; doi: 10.1016/j.msard.2018.09.036
26.
RoccaMA, VacchiL, RodegherM, et al.Mapping face encoding using functional MRI in multiple sclerosis across disease phenotypes. Brain Imaging Behav, 2017; 11(5):1238–1247; doi: 10.1007/s11682-016-9591-9
27.
VacchiL, RoccaMA, MeaniA, et al.Working memory network dysfunction in relapse-onset multiple sclerosis phenotypes: A clinical-imaging evaluation. Mult Scler, 2017; 23(4):577–587; doi: 10.1177/1352458516656809
28.
FarinottiM, VacchiL, SimiS, et al.Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev, 2012; 12:CD004192; doi: 10.1002/14651858.CD004192.pub3
29.
ParksNE, Jackson-TarltonCS, VacchiL, et al.Dietary interventions for multiple sclerosis-related outcomes. Cochrane Database Syst Rev, 2020; 5:CD004192; doi: 10.1002/14651858.CD004192.pub4
30.
BagurMJ, MurciaMA, Jiménez-MonrealAM, et al.Influence of diet in multiple sclerosis: A systematic review. Adv Nutr, 2017; 8(3):463–472; doi: 10.3945/an.116.014191
31.
KruppLB.Fatigue in multiple sclerosis: Definition, pathophysiology and treatment. CNS Drugs, 2003; 17(4):225–234; doi: 10.2165/00023210-200317040-00002
32.
AmatoMP, BertolottoA, BrunelliR, et al.Management of pregnancy-related issues in multiple sclerosis patients: The need for an interdisciplinary approach. Neurol Sci, 2017; 38(10):1849–1858; doi: 10.1007/s10072-017-3081-8
33.
FuchsTA, JaworskiMG, YoungsM, et al.Preliminary support of a behavioral intervention for trait conscientiousness in multiple sclerosis. Int J MS Care, 2022; 24(2):45–53; doi: 10.7224/1537-2073.2021-005
34.
TagliabueF, GalassiL, MarianiP. The “Pandemic” of disinformation in COVID-19. SN Compr Clin Med, 2020; 2(9):1287–1289; doi: 10.1007/s42399-020-00439-1
35.
van der SmissenD, RietjensJAC, van Gemert-PijnenL, et al.Information needs of patients with chronic diseases and their relatives for web-based advance care planning: A qualitative interview study. BMC Palliat Care, 2021; 20(1):77; doi: 10.1186/s12904-021-00770-x
36.
NealWN, RichardsonEV, MotlRW. Informing the development of a mobile application for the physical activity guidelines in multiple sclerosis: A qualitative, pluralistic approach. Disabil Rehabil Assist Technol, 2022:1–9; doi: 10.1080/17483107.2022.2153937
37.
KurtzkeJF.Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 1983; 33(11):1444–1452; doi: 10.1212/wnl.33.11.1444
38.
RudickRA, CutterG, ReingoldS. The multiple sclerosis functional composite: A new clinical outcome measure for multiple sderosis trials. Mult Scler, 2002; 8(5):359–365; doi: 10.1191/1352458502ms845oa
39.
WendrichK, KrabbenborgL. Digital self-monitoring of multiple sclerosis: Interview study with Dutch health care providers on the expected new configuration of roles and responsibilities. JMIR Mhealth Uhealth, 2022; 10(4):e30224; doi: 10.2196/30224
40.
Van HeckeW, CostersL, DescampsA, et al.A novel digital care management platform to monitor clinical and subclinical disease activity in multiple sclerosis. Brain Sci, 2021; 11(9):1171; doi: 10.3390/brainsci11091171
41.
GanzettiM, GravesJS, HolmSP, et al.Neural correlates of digital measures shown by structural MRI: A post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis. J Neurol, 2023; 270(3):1624–1636; doi: 10.1007/s00415-022-11494-0
42.
GravesJS, GanzettiM, DondelingerF, et al.Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis. Ann Clin Transl Neurol, 2023; 10(2):166–180; doi: 10.1002/acn3.51705
43.
MidagliaL, MuleroP, MontalbanX, et al.Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: Nonrandomized interventional feasibility study. J Med Internet Res, 2019; 21(8):e14863; doi: 10.2196/14863
44.
MontalbanX, GravesJ, MidagliaL, et al.A smartphone sensor-based digital outcome assessment of multiple sclerosis. Mult Scler, 2022; 28(4):654–664; doi: 10.1177/13524585211028561
45.
van der WaltA, ButzkuevenH, ShinRK, et al.Developing a digital solution for remote assessment in multiple sclerosis: From concept to software as a medical device. Brain Sci, 2021; 11(9):1427; doi: 10.3390/brainsci11091247
46.
WoelfleT, PlessS, WiencierzA, et al.Practice effects of mobile tests of cognition, dexterity, and mobility on patients with multiple sclerosis: Data analysis of a smartphone-based observational study. J Med Internet Res, 2021; 23(11):e30394; doi: 10.2196/30394
47.
RaoSM, LosinskiG, MouranyL, et al.Processing speed test: Validation of a self-administered, iPad. Mult Scler, 2017; 23(14):1929–1937; doi: 10.1177/1352458516688955
48.
WendrichK, KrabbenborgL.Negotiating with digital self-monitoring: A qualitative study on how patients with multiple sclerosis use and experience digital self-monitoring within a scientific study. Health (London), 2023:13634593231175321; doi: 10.1177/13634593231175321
49.
BevensW, GrayK, NeateSL, et al.Characteristics of mHealth app use in an international sample of people with multiple sclerosis. Mult Scler Relat Disord, 2021; 54:103092; doi: 10.1016/j.msard.2021.103092
50.
WendrichK, van OirschotP, MartensMB, et al.Toward digital self-monitoring of multiple sclerosis: Investigating first experiences, needs, and wishes of people with MS. Int J MS Care, 2019; 21(6):282–291; doi: 10.7224/1537-2073.2018-083
51.
AlMarshediA, WillsG, RanchhodA. Guidelines for the gamification of self-management of chronic illnesses: Multimethod study. JMIR Serious Games, 2017; 5(2):e12; doi: 10.2196/games.7472
52.
DamanabiS, SalimzadehZ, KalankeshLR, et al.Exploring self-management needs of persons with multiple sclerosis: A qualitative study for mobile application development. Int J MS Care, 2022; 24(1):1–7; doi: 10.7224/1537-2073.2019-129
53.
HillmanL.Caregiving in multiple sclerosis. Phys Med Rehabil Clin N Am, 2013; 24(4):619–627; doi: 10.1016/j.pmr.2013.06.007
54.
CortezNG, CohenIG, KesselheimAS. FDA regulation of mobile health technologies. N Engl J Med, 2014; 371(4):372–379; doi: 10.1056/NEJMhle1403384
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
